The Group's principal activities are to manufacture and market chemical and bio-pharmaceutical products. The products include pesticides, vaccines, life saving drugs, paints and other decoration materials, clinical diagnostic kits etc. The Group has a research and development division that incorporates the areas of drug discovery, chemistry of natural products and synthesis and has over 580 patents in its portfolio. The Group is also involved in the acquisition and refurbishment of real estate for lease.
Alacra Alerts:
Receive alerts on the latest reports on Zeltia SA
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
